297 related articles for article (PubMed ID: 21680634)
1. A novel FK-506-binding-like protein that lacks peptidyl-prolyl isomerase activity is involved in intracellular infection and in vivo virulence of Burkholderia pseudomallei.
Norville IH; Breitbach K; Eske-Pogodda K; Harmer NJ; Sarkar-Tyson M; Titball RW; Steinmetz I
Microbiology (Reading); 2011 Sep; 157(Pt 9):2629-2638. PubMed ID: 21680634
[TBL] [Abstract][Full Text] [Related]
2. A Burkholderia pseudomallei macrophage infectivity potentiator-like protein has rapamycin-inhibitable peptidylprolyl isomerase activity and pleiotropic effects on virulence.
Norville IH; Harmer NJ; Harding SV; Fischer G; Keith KE; Brown KA; Sarkar-Tyson M; Titball RW
Infect Immun; 2011 Nov; 79(11):4299-307. PubMed ID: 21859853
[TBL] [Abstract][Full Text] [Related]
3. Peptidyl-Prolyl Isomerase
Bzdyl NM; Scott NE; Norville IH; Scott AE; Atkins T; Pang S; Sarovich DS; Coombs G; Inglis TJJ; Kahler CM; Sarkar-Tyson M
Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31331957
[No Abstract] [Full Text] [Related]
4. BPSS1504, a cluster 1 type VI secretion gene, is involved in intracellular survival and virulence of Burkholderia pseudomallei.
Hopf V; Göhler A; Eske-Pogodda K; Bast A; Steinmetz I; Breitbach K
Infect Immun; 2014 May; 82(5):2006-15. PubMed ID: 24595140
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of bpsl1039-1040 ATP-binding cassette transporter reduces intracellular survival in macrophages, biofilm formation and virulence in the murine model of Burkholderia pseudomallei infection.
Pinweha P; Pumirat P; Cuccui J; Jitprasutwit N; Muangsombut V; Srinon V; Boonyuen U; Thiennimitr P; Vattanaviboon P; Cia F; Willcocks S; Bancroft GJ; Wren BW; Korbsrisate S
PLoS One; 2018; 13(5):e0196202. PubMed ID: 29771915
[TBL] [Abstract][Full Text] [Related]
6. In silico prediction of host-pathogen protein interactions in melioidosis pathogen Burkholderia pseudomallei and human reveals novel virulence factors and their targets.
Loaiza CD; Duhan N; Lister M; Kaundal R
Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32444871
[TBL] [Abstract][Full Text] [Related]
7. Attenuated virulence and protective efficacy of a Burkholderia pseudomallei bsa type III secretion mutant in murine models of melioidosis.
Stevens MP; Haque A; Atkins T; Hill J; Wood MW; Easton A; Nelson M; Underwood-Fowler C; Titball RW; Bancroft GJ; Galyov EE
Microbiology (Reading); 2004 Aug; 150(Pt 8):2669-2676. PubMed ID: 15289563
[TBL] [Abstract][Full Text] [Related]
8. Systematic mutagenesis of genes encoding predicted autotransported proteins of Burkholderia pseudomallei identifies factors mediating virulence in mice, net intracellular replication and a novel protein conferring serum resistance.
Lazar Adler NR; Stevens MP; Dean RE; Saint RJ; Pankhania D; Prior JL; Atkins TP; Kessler B; Nithichanon A; Lertmemongkolchai G; Galyov EE
PLoS One; 2015; 10(4):e0121271. PubMed ID: 25830295
[TBL] [Abstract][Full Text] [Related]
9. Distinct Pathogenic Patterns of
Chen YL; Hsu DW; Hsueh PT; Chen JA; Shih PJ; Lee S; Lin HH; Chen YS
Am J Trop Med Hyg; 2019 Oct; 101(4):736-745. PubMed ID: 31392941
[No Abstract] [Full Text] [Related]
10. An Inv/Mxi-Spa-like type III protein secretion system in Burkholderia pseudomallei modulates intracellular behaviour of the pathogen.
Stevens MP; Wood MW; Taylor LA; Monaghan P; Hawes P; Jones PW; Wallis TS; Galyov EE
Mol Microbiol; 2002 Nov; 46(3):649-59. PubMed ID: 12410823
[TBL] [Abstract][Full Text] [Related]
11. Virulence of the emerging pathogen,
Willcocks SJ; Denman C; Cia F; McCarthy E; Cuccui J; Wren BW
Future Microbiol; 2020 Mar; 15():241-257. PubMed ID: 32271107
[No Abstract] [Full Text] [Related]
12. The serine protease inhibitor Ecotin is required for full virulence of Burkholderia pseudomallei.
Ireland PM; Marshall L; Norville I; Sarkar-Tyson M
Microb Pathog; 2014; 67-68():55-8. PubMed ID: 24462575
[TBL] [Abstract][Full Text] [Related]
13. Flagella are virulence determinants of Burkholderia pseudomallei.
Chua KL; Chan YY; Gan YH
Infect Immun; 2003 Apr; 71(4):1622-9. PubMed ID: 12654773
[TBL] [Abstract][Full Text] [Related]
14. The lytic transglycosylase, LtgG, controls cell morphology and virulence in Burkholderia pseudomallei.
Jenkins CH; Wallis R; Allcock N; Barnes KB; Richards MI; Auty JM; Galyov EE; Harding SV; Mukamolova GV
Sci Rep; 2019 Jul; 9(1):11060. PubMed ID: 31363151
[TBL] [Abstract][Full Text] [Related]
15. The cluster 1 type VI secretion system is a major virulence determinant in Burkholderia pseudomallei.
Burtnick MN; Brett PJ; Harding SV; Ngugi SA; Ribot WJ; Chantratita N; Scorpio A; Milne TS; Dean RE; Fritz DL; Peacock SJ; Prior JL; Atkins TP; Deshazer D
Infect Immun; 2011 Apr; 79(4):1512-25. PubMed ID: 21300775
[TBL] [Abstract][Full Text] [Related]
16. Characterization of Burkholderia pseudomallei infection and identification of novel virulence factors using a Caenorhabditis elegans host system.
Gan YH; Chua KL; Chua HH; Liu B; Hii CS; Chong HL; Tan P
Mol Microbiol; 2002 Jun; 44(5):1185-97. PubMed ID: 12068805
[TBL] [Abstract][Full Text] [Related]
17. A proteasome inhibitor produced by Burkholderia pseudomallei modulates intracellular growth.
Wagley S; Vanaporn M; Rinchai D; Conejero L; Lertmemongkolchai G; Bancroft GJ; Titball RW
Microb Pathog; 2017 Jun; 107():175-180. PubMed ID: 28323151
[TBL] [Abstract][Full Text] [Related]
18. Identification of Burkholderia pseudomallei genes required for the intracellular life cycle and in vivo virulence.
Pilatz S; Breitbach K; Hein N; Fehlhaber B; Schulze J; Brenneke B; Eberl L; Steinmetz I
Infect Immun; 2006 Jun; 74(6):3576-86. PubMed ID: 16714590
[TBL] [Abstract][Full Text] [Related]
19. Virulence of the Melioidosis Pathogen Burkholderia pseudomallei Requires the Oxidoreductase Membrane Protein DsbB.
McMahon RM; Ireland PM; Sarovich DS; Petit G; Jenkins CH; Sarkar-Tyson M; Currie BJ; Martin JL
Infect Immun; 2018 May; 86(5):. PubMed ID: 29440370
[TBL] [Abstract][Full Text] [Related]
20. Role for the Burkholderia pseudomallei type three secretion system cluster 1 bpscN gene in virulence.
D'Cruze T; Gong L; Treerat P; Ramm G; Boyce JD; Prescott M; Adler B; Devenish RJ
Infect Immun; 2011 Sep; 79(9):3659-64. PubMed ID: 21768285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
